Intelligent Bio Solutions (INBS) Gains from Investment Securities (2021 - 2023)

Intelligent Bio Solutions (INBS) recorded quarterly Gains from Investment Securities of $1386.0 in Q2 2023, little changed quarter-over-quarter from $1386.0 in Q1 2023.

Intelligent Bio Solutions (INBS) Gains from Investment Securities (2021 - 2023) Analysis & Trends

Intelligent Bio Solutions' Gains from Investment Securities history runs 3 years deep, the most recent figure standing at $1386.0 for Q2 2023.

  • In Q2 2023, Gains from Investment Securities changed N/A year-over-year to $1386.0; the TTM figure through Jun 2023 stood at $1386.0 (changed N/A YoY), while the FY2023 annual figure was $1386.0, changed N/A from the prior year.
  • Gains from Investment Securities was $1386.0 for Q2 2023 at Intelligent Bio Solutions, roughly flat from $1386.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $27706.0 in Q4 2022 to a low of -$362667.0 in Q2 2021.
  • Historically, Gains from Investment Securities has averaged -$83047.2 across 3 years, with a median of $1386.0 in 2023.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Intelligent Bio Solutions 12.67 Mn 11.47 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2023 1,386.00
Jun 30, 2023 1,386.00
Mar 31, 2023 1,386.00
Mar 31, 2023 1,386.00
Dec 31, 2022 27,706.00
Dec 31, 2022 27,706.00
Jun 30, 2021 -362,667.00
Jun 30, 2021 -362,667.00